SEC Filing Analysis: QUEST DIAGNOSTICS INC (DGX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Quest Diagnostics conducted a pre-planned, $1.5M "sell-to-cover" transaction by exercising stock options and immediately selling the acquired shares under a Rule 10b5-1 plan.
• Market Impact: The transaction is immaterial, representing less than 0.01% of the company's market capitalization and shares outstanding, and is unlikely to influence the market.

Company Information

Field	Value
Company	QUEST DIAGNOSTICS INC
Ticker Symbol	DGX
CIK	0001022079
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	DELANEY MARK E
CIK	0001955265
Title/Position	SVP & Chief Commercial Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-18
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	7,946
Price Per Share	$187.35
Total Value	$1,488,968.10
Shares Owned After	7,530
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$1,488,968.10
% of Market Cap	0.0072%
Shares Transacted	7,946
% of Shares Outstanding	0.0071%
Post-Transaction Ownership	7,530 shares (0.0067% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a large-cap company with a $20.80 billion market capitalization, a transaction of approximately $1.5 million is considered routine and financially insignificant.
• Ownership Concentration: The insider's post-transaction holding of 7,530 shares constitutes a very small fraction (0.0067%) of the total shares outstanding, indicating low ownership concentration.
• Transaction Significance: The sale, while representing over 50% of the insider's holdings at the time, is negligible in the context of the overall market for DGX stock. Its low percentage of market cap and shares outstanding confirms its low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale was executed under a pre-arranged Rule 10b5-1 trading plan, which severs the link between the transaction and any potential non-public information the insider may possess. This, combined with the transaction's small size, suggests no market impact.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to have a noticeable effect on daily trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales for compensation and tax purposes are standard corporate procedure and do not typically influence market sentiment.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly states the transaction was part of a Rule 10b5-1 sales plan. The insider exercised 7,946 options at prices of $144.47 and $143.33 and simultaneously sold the same number of shares at the market price of $187.35. This is a classic "sell-to-cover" transaction.